Wockhardt launches $40m manufacturing plant in Dubai
July 30, 2018Manufacturing and Production, Sales and Marketing Antibiotics, Dubai, India, Wockhardt, antibiotic resistance, pharma
Indian pharmaceutical firm Wockhardt has launched its first manufacturing facility in Dubai’s Jebel Ali Free Zone (Jafza). Costing $40 million, …
EU Commission grants market authorisation for Sandoz’ Humira biosimilar
July 30, 2018Sales and Marketing FDA, Sandoz, approval, biosimilar, european commision
The European Commission has granted marketing authorisation to Sandoz’ biosimilar Hyrimoz for use in all indications, including rheumatoid arthritis, plaque …
Gilead’s CEO and Chairman to both step down before year’s end
July 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma
Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
Living with Behçet’s disease
July 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Behçet's disease, patient experience, pharma
Suzanne Morris speaks to Pharmafocus to discuss her life with Behçet’s disease, a rare condition characterised by the inflammation of …
CHMP recommend white blood cell growth stimulator biosimilar to EMA
July 30, 2018Sales and Marketing Amgen, CHMP, EMA, Neulasta, biosimilar, chemotherapy, pegfilgrastim
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of two separate …
Tonix plunges 68% after PTSD drug failure
July 30, 2018Research and Development, Sales and Marketing PTSD, Tonmya, pharma, tonix
Tonix Pharmaceuticals has announced that it has terminated its Phase 3 study of Tonmya (cyclobenzaprine HCl sublingual tablets) in military-related …
Army to ferry medicines in case of no-deal Brexit
July 30, 2018Sales and Marketing UK, army, brexit, medicines, pharma, politics, supply chains
Ministers have established plans to use the army to deliver medicines, food and fuel in the event of a no-deal …
Amgen announces resignation of two top executives
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Anthony C Cooper, R&D, biotech, retire, sean harper
Amgen’s head of R&D, Dr Sean Harper, has announced that he is retiring from his current position as Executive Vice …
Top Ten most popular articles on Pharmafile.com this week
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra
With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …
Those at risk of HIV to be offered PrEP drugs in England and Northern Ireland
July 27, 2018Medical Communications AIDS, England, HIV, PrEP, Terrence Higgins Trust
Those at risk of contracting HIV will now be offered PrEP drugs in England and Northern Ireland through a programme …
Takeda’s Alunbrig topples Pfizer’s Xalkori in ALK-positive lung cancer
July 27, 2018Medical Communications, Research and Development Alunbrig, Cancer, NSCLC, Pfizer, Takeda, Xalkori, lung cancer, pharma
Takeda has unveiled new Phase 3 data showing that its tyrosine kinase inhibitor (TKI) Alunbrig (brigatinib) not only met its …
Landlord demands EMA pay £500m for Canary Wharf lease
July 27, 2018Medical Communications Canary Wharf, EMA, Litigation, London, amsterdam, court
A British landlord is taking the European Medicines Agency (EMA) to court over a £500 million bill for unpaid rent. …
Cannabis-derived medicinal products to become available in UK
July 26, 2018Medical Communications cannabis, law, medicinal marijuana, prescription, sajid javid, schedule drugs, uk politics
Home Secretary Sajid Javid has announced that cannabis derived medicinal products will be made available on prescription “by the autumn” …
GSK forges $300m partnership with 23andMe to boost preclinical R&D
July 26, 2018Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma
In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …
Merck KGaA announces new Senior Vice President, Head of Global Affairs
July 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Maria Rivas, Germany, Merck, Merck KGaA, research and development
Merck KGaA has announced the appointment of Dr Maria Rivas as Senior Vice President, Head of Global Affairs. Dr Rivas, …
Gilead’s CEO and Chairman to both step down before year’s end
July 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma
Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
AstraZeneca announces price freezes while earnings drop by 28%
July 26, 2018Business Services, Sales and Marketing AstraZeneca, Trump, price freezes, price hikes
The Anglo-Swedish drug maker AstraZeneca has joined Pfizer and others in halting price hikes until the end of 2018. AstraZeneca …
Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials
July 26, 2018Research and Development Alzheimer's disease, BAN2401, Biodgen, Eisai, phase 2, research
An experimental drug developed by the Massachusetts-based multinational Biogen and their Japanese partner Eisai has been shown to significantly slow …
NHS to stockpile drugs in preparation for no-deal Brexit
July 25, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, brexit, government, pharma, stockpiling
Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines …
FDA approves first endometriosis pain management drug in a decade
July 25, 2018Research and Development, Sales and Marketing AbbVie, FDA, Neurocrine Biosciences, endometriosis, pharma
The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
